Drug Shortage Report for CONSTELLA

Last updated on 2019-01-09 History
Report ID 67153
Drug Identification Number 02417170
Brand name CONSTELLA
Common or Proper name CONSTELLA 290MCG CAP 30 CA
Market Status MARKETED
Active Ingredient(s) Linaclotide
Strength(s) 290MCG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 290MCG CAP 30
ATC code A06AX
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-11-09
Estimated end date 2018-12-20
Actual end date 2018-12-19
Shortage status Resolved
Updated date 2019-01-09
Company comments Delay with the release of new products supply for 290 mcg only. 72 & 145 mcg are available.
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-01-09 French Compare
v10 2019-01-09 English Compare
v9 2018-12-14 French Compare
v8 2018-12-14 English Compare
v7 2018-11-30 French Compare
v6 2018-11-30 English Compare
v5 2018-11-20 French Compare
v4 2018-11-20 English Compare
v3 2018-11-20 English Compare
v2 2018-11-20 English Compare
v1 2018-11-20 English Compare

Showing 1 to 11 of 11